Nyxoah SA
Develops hypoglossal neurostimulation therapy for Obstructive Sleep Apnea (OSA).
NYXH | BR
Overview
Corporate Details
- ISIN(s):
- BE0974358906
- LEI:
- 5493002O1ESKZ18OXR80
- Country:
- Belgium
- Address:
- Rue Edouard Belin 12, 1435 Mont-Saint-Guibert
- Website:
- https://www.nyxoah.com/
- Sector:
- Manufacturing
Description
Nyxoah SA is a medical technology company focused on the development and commercialization of solutions for Obstructive Sleep Apnea (OSA). The company's lead product is the Genio® system, a hypoglossal neurostimulation (HNS) therapy designed for patients with moderate to severe OSA. The system features a patient-centered, leadless, and battery-free implantable stimulator. It functions by providing bilateral stimulation to the hypoglossal nerve, which controls tongue muscles, to maintain an open airway during sleep.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-06-25 09:00 |
20210625 - Special board report - Art 7_179_7_191_7_193 - US IPO (ENG) (for web…
|
English | 722.7 KB | ||
| 2021-06-25 09:00 |
20210625 - Special board report - Art 7_179_7_191_7_193 - US IPO (FR) (for webs…
|
French | 650.7 KB | ||
| 2021-06-11 09:00 |
Nyxoah - 2021 ASM - Minutes - ENG (final).pdf
|
English | 266.3 KB | ||
| 2021-06-11 09:00 |
Nyxoah - 2021 ASM - Minutes - FR (final).pdf
|
French | 242.5 KB | ||
| 2021-06-10 23:45 |
20210610_Nyxoah_Interim FS - Q1 2021_NYXH-Clean V2.pdf
|
English | 605.7 KB | ||
| 2021-06-10 23:45 |
english-q1-results-pr.pdf
|
English | 209.5 KB | ||
| 2021-06-10 23:45 |
french-q1-results-pr.pdf
|
French | 232.8 KB | ||
| 2021-06-10 23:30 |
Nyxoah files Registration Statement for Proposed Initial Public Offering in the…
|
English | 146.4 KB | ||
| 2021-06-10 23:30 |
Nyxoah dépose une déclaration d'enregistrement pour l'offre publique initiale p…
|
French | 170.5 KB | ||
| 2021-06-07 07:00 |
Nyxoah BETTER SLEEP Trial Reaches its Primary Endpoints
|
English | 176.4 KB | ||
| 2021-06-07 07:00 |
L'étude BETTER SLEEP de Nyxoah atteint ses objectifs principaux
|
French | 177.0 KB | ||
| 2021-05-26 19:00 |
PR Transparency notification 2021 05 26 (BNP) (ENG).pdf
|
English | 167.1 KB | ||
| 2021-05-26 19:00 |
PR Transparency notification 2021 05 26 (BNP) (FR).pdf
|
French | 167.7 KB | ||
| 2021-05-07 09:00 |
Nyxoah - Form for voting by mail - ENG FR.pdf
|
French | 291.3 KB | ||
| 2021-05-07 09:00 |
Statutory annual accounts RESTATED 2019 French.PDF
|
French | 8.6 MB |
Automate Your Workflow. Get a real-time feed of all Nyxoah SA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Nyxoah SA
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Nyxoah SA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-11-19 | Laurette Renard | Close relation | Sell | 5,000 | 39,000.00 EUR |
| 2024-09-05 | Hambrecht Jürgen | Board | Sell | 980,000 | 6,840,400.00 EUR |
| 2024-09-05 | JH Capital GmbH | Close relation | Buy | 980,000 | 6,840,400.00 EUR |
| 2024-01-25 | Tompkins Patrick | Executive member | Buy | 2,000 | 18,020.00 USD |
| 2023-12-28 | Onkelinx Bruno | Executive member | Buy | 470 | 2,035.10 EUR |
| 2023-08-18 | Moreau Loïc | Executive member | Buy | 6,427 | 48,416.52 EUR |
| 2023-08-14 | Moreau Loïc | Executive member | Buy | 3,800 | 28,697.60 EUR |
| 2023-08-11 | Moreau Loïc | Executive member | Buy | 3,000 | 21,957.60 EUR |
| 2023-07-04 | Wildman Ventures LLC | Board | Buy | 25,000 | N/A |
| 2023-07-02 | Gianello Pierre | Board | Buy | 25,000 | N/A |
Peer Companies
